UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050010
Receipt number R000056921
Scientific Title The observation of knee joint for healthy adult males and females.
Date of disclosure of the study information 2023/01/28
Last modified on 2023/01/11 11:02:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The observation of knee joint for healthy adult males and females.

Acronym

The observation of knee joint for healthy adult males and females.

Scientific Title

The observation of knee joint for healthy adult males and females.

Scientific Title:Acronym

The observation of knee joint for healthy adult males and females.

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The observation of the knee for healthy adult males and females.

Basic objectives2

Others

Basic objectives -Others

None

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

None

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Get two MRI scans of the knee joint per day

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

25 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy adult males and females

Key exclusion criteria

1. Persons who are unable to perform MRI imaging
2. Other subjects deemed unsuitable by the research institution or study site

Target sample size

3


Research contact person

Name of lead principal investigator

1st name Yasunori
Middle name
Last name Matsui

Organization

KOBAYASHI Pharmaceutical Co.,Ltd

Division name

Central R&D Laboratory

Zip code

567-0057

Address

1-30-3, Toyokawa, Ibaraki-city, Osaka

TEL

080-3452-9761

Email

y.matsui@kobayashi.co.jp


Public contact

Name of contact person

1st name Yoshiyuki
Middle name
Last name Mizushina

Organization

KOBAYASHI Pharmaceutical Co.,Ltd

Division name

Central R&D Laboratory

Zip code

567-0057

Address

1-30-3, Toyokawa, Ibaraki-city, Osaka

TEL

080-4063-7709

Homepage URL


Email

y.mizushina@kobayashi.co.jp


Sponsor or person

Institute

KOBAYASHI Pharmaceutical Co.,Ltd

Institute

Department

Personal name



Funding Source

Organization

KOBAYASHI Pharmaceutical Co.,Ltd

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiba Palace Clinic Ethics Committee

Address

DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN

Tel

03-5408-1590

Email

jimukyoku@mail.souken-r.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 01 Month 06 Day

Date of IRB


Anticipated trial start date

2023 Year 01 Month 29 Day

Last follow-up date

2024 Year 01 Month 29 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 01 Month 11 Day

Last modified on

2023 Year 01 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056921


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name